Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06086899

The Efficacy and Safety of Early MSAT on Radiating Pain in the Upper Extremity

Conditions: Radiating Pain in the Upper Extremity

Sex: All
Ages: 19 Years – 69 Years
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: Jaseng Medical Foundation

Location: Jaseng Hospital of Korean Medicine Seoul Gangnam-Gu

Summary

This study is a open-label, randomized controlled trail. condition/disease: radiating pain in the upper extremity. treatment/intervention: motion style acupuncture treatment

Eligibility Criteria

Inclusion Criteria: * Patients aged 19-69 years on the date they sign the consent form. * Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident. * Patients who are hospitalized due to traffic accident. * Patients with NRS of radiating pain ≥ 5. * Patients who provide consent to participate in the trial and return the informed consent form. Exclusion Criteria: * Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients with progressive neurological deficits or with severe neurological symptoms. * Patients with medical history of cervical surgery or thoracic surgery within the last three weeks. * Patients who have radiating pain in upper extremity before the traffic accident. * Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study. * If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease. * Patients who are pregnant or planning to become pregnant. * Patients who are participated in clinical trials other than observational studies without therapeutic intervention. * Patients who are difficult to complete the research participation agreement. * Other patients whose participation in the trial is judged by a researcher to be problematic.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06086899). StuddyBuddy aggregates publicly available trial information.